A niosome-in-chitosan gel hybrid system for topical moxifloxacin delivery is proposed.
The moxifloxacin niosomal gel systems exhibited sustainable release behaviors.
The hybrid system showed adequate bioadhesiveness and pseudo-plastic flow behavior.
Niosomal formulation showed a higher antibacterial activity against P. aeruginosa.
Chitosan gels markedly enhanced the efficacy of moxifloxacin against S. aureus.